U.S. flag

An official website of the United States government

NM_000264.5(PTCH1):c.3333del (p.Asn1112fs) AND Gorlin syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 7, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002007549.4

Allele description [Variation Report for NM_000264.5(PTCH1):c.3333del (p.Asn1112fs)]

NM_000264.5(PTCH1):c.3333del (p.Asn1112fs)

Gene:
PTCH1:patched 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
9q22.32
Genomic location:
Preferred name:
NM_000264.5(PTCH1):c.3333del (p.Asn1112fs)
HGVS:
  • NC_000009.12:g.95453594del
  • NG_007664.1:g.68372del
  • NM_000264.5:c.3333delMANE SELECT
  • NM_001083602.3:c.3135del
  • NM_001083603.3:c.3330del
  • NM_001083604.3:c.2880del
  • NM_001083605.3:c.2880del
  • NM_001083606.3:c.2880del
  • NM_001083607.3:c.2880del
  • NM_001354918.2:c.3177del
  • NP_000255.2:p.Asn1112fs
  • NP_001077071.1:p.Asn1046fs
  • NP_001077072.1:p.Asn1111fs
  • NP_001077073.1:p.Asn961fs
  • NP_001077074.1:p.Asn961fs
  • NP_001077075.1:p.Asn961fs
  • NP_001077076.1:p.Asn961fs
  • NP_001341847.1:p.Asn1060fs
  • LRG_515:g.68372del
  • NC_000009.11:g.98215876del
  • NR_149061.2:n.4072del
Protein change:
N1046fs
Links:
dbSNP: rs2136632164
NCBI 1000 Genomes Browser:
rs2136632164
Molecular consequence:
  • NM_000264.5:c.3333del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001083602.3:c.3135del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001083603.3:c.3330del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001083604.3:c.2880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001083605.3:c.2880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001083606.3:c.2880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001083607.3:c.2880del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354918.2:c.3177del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_149061.2:n.4072del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Gorlin syndrome
Synonyms:
Basal cell nevus syndrome
Identifiers:
MONDO: MONDO:0007187; MedGen: C0004779; Orphanet: 377; OMIM: PS109400

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002234132Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(May 7, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinical testing for the nevoid basal cell carcinoma syndrome in a DNA diagnostic laboratory.

Klein RD, Dykas DJ, Bale AE.

Genet Med. 2005 Nov-Dec;7(9):611-9.

PubMed [citation]
PMID:
16301862

PTCH mutations: distribution and analyses.

Lindström E, Shimokawa T, Toftgård R, Zaphiropoulos PG.

Hum Mutat. 2006 Mar;27(3):215-9. Review.

PubMed [citation]
PMID:
16419085
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002234132.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Asn1112Thrfs*27) in the PTCH1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PTCH1 are known to be pathogenic (PMID: 16301862, 16419085). This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with PTCH1-related conditions.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024